PDA management in VLBW infants: experience of a level III NICU

PDA management in VLBW infants: experience of a level III NICU

Introduction: Hemodynamically significant patent ductus arteriosus (PDA) is a common condition in very low birth weight infants. Therapeutic options include medical therapy and surgical ligation. Medical treatment is based on non-selective inhibitors of cyclooxygenases 1 and 2 (indomethacin and ibup...

Full description

Bibliographic Details
Main Authors:	Ana Oliveira, Paulo Soares, Filipa Flor-de-Lima, Ana Luísa Neves, Hercília Guimarães
Format:	Article
Language:	English
Published:	Hygeia Press di Corridori Marinella 2016-08-01
Series:	Journal of Pediatric and Neonatal Individualized Medicine
Subjects:	patent ductus arteriosus ibuprofen indomethacin efficacy morbidities very low birth weight
Online Access:	https://www.jpnim.com/index.php/jpnim/article/view/407

Similar Items

Comparison of Therapeutic Effects and Side Effects of Oral Ibuprofen and Indomethacin on the Closure of Patent Ductus Arteriosus in Premature Infants
by: P Sadeghi-Moghaddam, et al.
Published: (2017-09-01)

Oral Ibuprofen versus Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
by: Cheng Han Lee, et al.
Published: (2012-12-01)

Patent ductus arteriosus (PDA): Recent recommendations for to close or not to close
by: Yasemin Ezgi Köstekci, et al.
Published: (2024-03-01)

Comparison of oral ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in extremely low birth weight infants
by: Eun Mi Yang, et al.
Published: (2013-01-01)

Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series
by: Ayumi Oshima, et al.
Published: (2020-01-01)

A decision aid for considering indomethacin prophylaxis vs. symptomatic treatment of PDA for extreme low birth weight infants
by: AlKharfi Turki M, et al.
Published: (2011-09-01)

Comparison of Various Pharmacologic Agents in the Management of Hemodynamically Significant Patent Ductus Arteriosus in Preterm: A Network Meta-Analysis and Risk-Benefit Analysis
by: Sudarat Eursiriwan, et al.
Published: (2022-10-01)

Comparative Study of PDA Ligation in the OR versus in the NICU: A 10-Year Retrospective Cohort Study
by: Kittipatr Poopong, et al.
Published: (2024-01-01)

A Major Cause of Mortality and Morbidity of Very Low Birth Weight Infants: Patent Ductus Arteriosus
by: Fatih Aygün, et al.
Published: (2012-04-01)

Comparison of gastrointestinal complications of paracetamol and ibuprofen in the management of infants with patent ductus arteriosus: A randomized clinical trial study
by: Gohar Shahmirzadi, et al.
Published: (2021-01-01)

Early or Late Surgical Ligation of Medical Refractory Patent Ductus Arteriosus in Premature Infants
by: Chien-Chou Hsiao, et al.
Published: (2009-01-01)

Effects of Intravenous Indomethacin on Reduction of Symptomatic Patent Ductus Arteriosus Cases and Decreasing the Need for Prolonged Mechanical Ventilation
by: Jannatdoust Abdollah, et al.
Published: (2014-12-01)

Molecular and Mechanical Mechanisms Regulating Ductus Arteriosus Closure in Preterm Infants
by: Fahri Ovalı
Published: (2020-08-01)

Effect of oral Ibuprofen in ductus arteriosus closure in preterm infants
by: Mohagheghi P (MD), et al.
Published: (2010-06-01)

Personalized Evidence-Based Management of Patent Ductus Arteriosus in Preterm Infants
by: Belinda Chan, et al.
Published: (2023-12-01)

Evaluation the Effectiveness of Ibuprofen in Improving Patent Ductus Arteriosus
by: Maryam Beheshtifard, et al.
Published: (2021-09-01)

Evaluation the Effectiveness of Ibuprofen in Improving Patent Ductus Arteriosus
by: Maryam Beheshtifard, et al.
Published: (2021-09-01)

Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
by: Mehdi Ghaderian, et al.
Published: (2019-01-01)

THE EFFICACY, SIDE-EFFECTS, AND MORTALITY COMPARISON BETWEEN PARACETAMOL AND IBUPROFEN IN PATENT DUCTUS ARTERIOSUS TREATMENT FOR PREMATURE INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: Lokot Donna Lubis
Published: (2021-11-01)

Risk factors for PDA ligation and neurodevelopmental outcomes at corrected 18–24 months in very low birth weight infants
by: Sol Kim, et al.
Published: (2024-05-01)

Velocity time integral for right upper pulmonary vein in VLBW infants with patent ductus arteriosus
by: Gianluca Lista, et al.

Efficacy of Paracetamol in Closure of Ductus Arteriosus in Infants under 32 Weeks of Gestation
by: Ines Tofe, et al.
Published: (2018-02-01)

Medical closure of patent ductus arteriosus does not reduce mortality and development of bronchopulmonary dysplasia in preterm infants
by: Demet Terek, et al.
Published: (2014-01-01)

Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis
by: Yingqi Xiao, et al.
Published: (2020-02-01)

Comparison of the Effectiveness of Paracetamol and Ibuprofen in the Management of Patent Ductus Arteriosus in Preterm Neonates: A Randomized Controlled Trial
by: S. Mohsin Ali Shah, et al.
Published: (2025-01-01)

Patent ductus arteriosus treatment in preterm neonates, which is the drug of choice paracetamol vs ibuprofen?
by: Reham S Abd Al Hamid
Published: (2020-01-01)

Positive tendency toward synchronous use of acetaminophen and ibuprofen in treating patients with patent ductus arteriosus
by: Roya Oboodi, et al.
Published: (2020-09-01)

Comparison of two dose regimens of ibuprofen for the closure of patent ductus arteriosus in preterm newborns
by: Laura Vargas Dornelles, et al.
Published: (2016-05-01)

Comparison of the Efficacy and Complications of Oral versus Intravenous Ibuprofen in Low-birth-weight Neonates with Patent Ductus Arteriosus: A Retrospective Cohort Study
by: Yazdan Ghandi, et al.
Published: (2022-10-01)

Is medical therapy succesful in hemodynamically significant patent ductus treatment in term newborns?
by: Akan Yaman, et al.
Published: (2024-01-01)

Pharmacological treatment strategies for neonates with patent ductus arteriosus: a systematic review
by: Oliver Emmanuel Yausep, et al.
Published: (2019-09-01)

Management of Patent Ductus Arteriosus in Term or Near-term Neonates With Respiratory Distress
by: Yu-Chen Lin, et al.
Published: (2010-06-01)

Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety
by: Haşim Olgun, et al.
Published: (2017-02-01)

Association between Fluid Balance and Treatment Outcome of Ibuprofen for Patent Ductus Arteriosus in Preterm Infants
by: Chang Liu, et al.
Published: (2023-03-01)

Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus
by: Janardhan Mydam, et al.
Published: (2019-08-01)

Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
by: Caterina Coviello, et al.
Published: (2020-09-01)

Current Controversy on Platelets and Patent Ductus Arteriosus Closure in Preterm Infants
by: Hannes Sallmon, et al.
Published: (2021-02-01)

Effect of ibuprofen for hemodynamically significant patent ductus arteriosus closure on the development of acute kidney injury in preterm infants
by: T.P. Borysova, et al.
Published: (2021-03-01)

Management of Patent Ductus Arteriosus in Premature Infants in 2020
by: Sarah Parkerson, et al.
Published: (2021-02-01)

PATENT DUCTUS ARTERIOSUS CLOSURE: EXPERIENCE FROM A TERTIARY REFERRAL CENTER
by: Diogo Remi Oliveira Faim, et al.
Published: (2020-11-01)